United Therapeutics Corp. (UTHR) PT Lowered to $203 at Ladenburg Thalmann
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $494.63 -0.53%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $203.00 (from $231.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Mapletree Logistics Trust (MLT:SP) (MAPGF) to Neutral
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
- Polaris Industries (PII) PT Lowered to $61 at UBS, Neutral Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
